4/A//SEC Filing
Ordemann Thomas 4/A
Accession 0001127602-09-023875
CIK 0001014739other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 12:18 PM ET
Size
9.1 KB
Accession
0001127602-09-023875
Insider Transaction Report
Form 4/AAmended
BioScrip, Inc.BIOS
Ordemann Thomas
Executive Vice President
Transactions
- Sale
Common Stock, $.0001 Par Value
2009-11-11$8.56/sh−41,260$353,202→ 20,250 total
Holdings
- 75,000
Option To Purchase Common Stock
Exercise: $2.73From: 2010-04-28Exp: 2019-04-28→ Common Stock, $.0001 Par Value (75,000 underlying) - 80,000
Option To Purchase Common Stock
Exercise: $5.46From: 2008-08-01Exp: 2017-08-01→ Common Stock, $.0001 Par Value (80,000 underlying) - 50,625
Option To Purchase Common Stock
Exercise: $6.52From: 2009-04-29Exp: 2018-04-29→ Common Stock, $.0001 Par Value (50,625 underlying)
Footnotes (2)
- [F1]Shares were sold at various prices between $8.49 and $8.60 per share. The reporting person undertakes to provide (upon request by the SEC staff, the issuer, or a security holder of the issuer) full information regarding the number of shares purchased or sold at each separate price.
- [F2]Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
Documents
Issuer
BioScrip, Inc.
CIK 0001014739
Entity typeother
Related Parties
1- filerCIK 0001430965
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 12:18 PM ET
- Size
- 9.1 KB